1887

Canine hypoadrenocorticism

image of Canine hypoadrenocorticism
GBP
Online Access: £ 25.00 + VAT
BSAVA Library Pass Buy a pass

Abstract

Canine hypoadrenocorticism is a rare syndrome in dogs characterized by a deficiency of adrenal cortex hormones, usually both glucocorticoids and mineralocorticoids (Addison’s disease). Most affected dogs have primary hypoadrenocorticism, most commonly due to immune-mediated destruction of the adrenal cortex. Diagnostic tests used to confirm the diagnosis of hypoadrenocorticism, such as the ACTH response test, are discussed along with the different treatment options, including glucocorticoid and mineralocorticoid replacement therapy. Guidance is provided on managing acute and chronic cases. The prognosis for dogs with hypoadrenocorticism is usually good with proper management and lifelong treatment.

Preview this chapter:
Loading full text...

Full text loading...

/content/chapter/10.22233/9781910443866.chap28

Figures

Image of 28.1
28.1 Outline of the unique steroid synthesis pathway in dogs. 3-beta-HSD = 3-beta-hydroxysteroid dehydrogenase; DHEA = dehydroepiandrosterone.
Image of 28.2
28.2 Diagram of the hypothalamic–pituitary–adrenal and renin–angiotensin–aldosterone system feedback pathways. ACE = angiotensin converting enzyme; ACTH = adrenocorticotropic hormone; CRH = corticotropin-releasing hormone; = stimulation; = inhibition. Drawn by S.J. Elmhurst BA Hons (www.livingart.org.uk) and reproduced with her permission.
Image of 28.3
28.3 Aldosterone action in the basolateral membrane of the kidney. (a) Without aldosterone, lower concentrations of sodium and potassium ions and water move through the principal cells between the tubular lumen and the renal interstitium. (b) With aldosterone, increased Na/K ATPase pumps create a diffusion gradient, which moves sodium and, subsequently, water from the tubular lumen through the principal cells to the renal interstitium and the body. Potassium moves in the opposite direction. Epithelial sodium channels allow more sodium to enter the principal cells, further increasing resorption. Drawn by S.J. Elmhurst BA Hons (www.livingart.org.uk) and reproduced with her permission.
Image of 28.11
28.11 Interpretation of adrenocorticotropic hormone (ACTH) response test results.
Image of 28.14
28.14 Desoxycorticosterone pivalate (DOCP) dosing flowchart. Change doses by 10–20% at each step. (Adapted from )
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error